Yannick Dieudonné

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 290 citations · Full text

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +9

Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry

Benjamin De Valence, M. Delaune, Yann Nguyen et al. · Annals of the Rheumatic Diseases · 2023 · 58 citations

Transitional B cells in quiescent SLE: An early checkpoint imprinted by IFN

Yannick Dieudonné, Vincent Gies, Aurélien Guffroy et al. · Journal of Autoimmunity · 2019 · 54 citations · Full text

Cell Regulation, Cell Division, Cell Interaction +7

Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement—A new target for lupus treatment

Nikaïa Smith, Mathieu P. Rodero, Nassima Bekaddour et al. · Science Advances · 2019 · 51 citations · Full text

Immune Defect in Adults With Down Syndrome: Insights Into a Complex Issue

Yannick Dieudonné, B. Uring‐Lambert, Mohamed Jeljeli et al. · Frontiers in Immunology · 2020 · 39 citations · Full text

Immunodeficiencies, Immunology, Immune Phenotype +16